SMAD5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.562000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.915600E-01
Normal-vs-Stage2
3.580600E-01
Normal-vs-Stage3
1.146140E-02
Normal-vs-Stage4
9.223000E-01
Stage1-vs-Stage2
1.360600E-01
Stage1-vs-Stage3
1.005630E-02
Stage1-vs-Stage4
8.070200E-01
Stage2-vs-Stage3
2.212900E-04
Stage2-vs-Stage4
3.741200E-01
Stage3-vs-Stage4
1.091800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.282400E-01
Normal-vs-AfricanAmerican
9.541600E-01
Normal-vs-Asian
4.248400E-01
Caucasian-vs-AfricanAmerican
3.296800E-01
Caucasian-vs-Asian
7.140000E-01
AfricanAmerican-vs-Asian
4.013800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.825000E-01
Normal-vs-Female
4.455600E-01
Male-vs-Female
8.786800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.191400E-01
Normal-vs-Age(41-60Yrs)
9.269200E-01
Normal-vs-Age(61-80Yrs)
2.994400E-01
Normal-vs-Age(81-100Yrs)
1.077580E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.994600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.192200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.686030E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.302750E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.712000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.312600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.460200E-01
Normal-vs-Daily Drinker
9.095800E-02
Normal-vs-Weekly Drinker
1.994170E-01
Normal-vs-Occasional Drinker
5.960000E-01
Normal-vs-Social Drinker
9.470800E-01
Non Drinker-vs-Daily Drinker
2.385400E-01
Non Drinker-vs-Weekly Drinker
5.841000E-01
Non Drinker-vs-Occasional Drinker
2.685400E-01
Non Drinker-vs-Social Drinker
1.225630E-01
Daily Drinker-vs-Weekly Drinker
6.692400E-01
Daily Drinker-vs-Occasional Drinker
4.405700E-02
Daily Drinker-vs-Social Drinker
3.469500E-02
Weekly Drinker-vs-Occasional Drinker
1.798230E-01
Weekly Drinker-vs-Social Drinker
8.479800E-02
Occasional Drinker-vs-Social Drinker
3.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.804200E-02
Normal-vs-Grade 2
5.383500E-03
Normal-vs-Grade 3
8.495400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.996400E-01
Grade 1-vs-Grade 3
4.217000E-01
Grade 1-vs-Grade 4
6.804200E-02
Grade 2-vs-Grade 3
9.952200E-01
Grade 2-vs-Grade 4
5.383500E-03
Grade 3-vs-Grade 4
8.495400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.830210E-01
Normal-vs-NonDiabetic
4.519000E-01
Diabetic-vs-NonDiabetic
2.260200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.034400E-01
Normal-vs-NoPancreatitis
4.143000E-01
Pancreatitis-vs-NoPancreatitis
7.030800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.838000E-01
Normal-vs-N1
3.342000E-01
N0-vs-N1
2.945400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.511800E-01
Normal-vs-TP53-NonMutant
9.494000E-01
TP53-Mutant-vs-TP53-NonMutant
1.784220E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
